Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy

被引:41
|
作者
Furling, D
Lam, LT
Agbulut, O
Butler-Browne, GS
Morris, GE
机构
[1] NE Wales Inst, Biochem Grp, Wrexham LL11 2AW, Wales
[2] Univ Paris 06, CNRS, UMR 7000, Paris, France
来源
AMERICAN JOURNAL OF PATHOLOGY | 2003年 / 162卷 / 03期
关键词
D O I
10.1016/S0002-9440(10)63894-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Myotonic dystrophy (DM1) is caused by the expansion of a CTG repeat in the noncoding region of a protein kinase, DMPK, expressed in skeletal and cardiac muscles. The aim of the present study was to determine the effects of very large CTG expansions on DMPK expression and skeletal muscle development. in fetuses suffering from the severe congenital form of DM1 with large CTG expansions (1800 to 3700 repeats), the skeletal muscle level of DMPK was reduced to 57% of control levels and a similar reduction was observed in cultured DM1 muscle cells relative to control cultures. These results are consistent with greatly reduced DMPK expression from the mutant allele and normal expression from the unaffected allele in this autosomal dominant disorder. In normal fetuses, DMPK protein levels increased dramatically between 9 and 16 weeks and remained high throughout the remaining gestation period. DM1 fetuses showed impaired skeletal muscle development, characterized by a persistence of embryonic and fetal myosin heavy chains and almost total absence of slow myosin heavy chains at the end of gestation. DMPK expression, however, was similar in both fast and slow fibers from normal adult muscle. The reduced DMPK and the delayed slow fiber maturation in congenital DM1 may be two separate consequences of nuclear retention of DMPK RNA transcripts with expanded CUG repeats.
引用
收藏
页码:1001 / 1009
页数:9
相关论文
共 50 条
  • [41] Clinical profile of congenital myotonic dystrophy
    Tian, C.
    Bange, J.
    Rybalslcy, I.
    Wong, B.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S212 - S212
  • [42] Congenital Myotonic Dystrophy with Asymptomatic Mother
    Anand, K. M.
    Biradar, V. M.
    Panicker, J. N.
    Nampoothiri, Sheela
    INDIAN PEDIATRICS, 2011, 48 (07) : 565 - 567
  • [43] CYSTINURIA WITH CONGENITAL MYOTONIC-DYSTROPHY
    KIMURA, S
    AMEMIYA, F
    FUKAZAWA, H
    PEDIATRIC NEUROLOGY, 1987, 3 (04) : 233 - 234
  • [44] Congenital myotonic dystrophy - A case report
    Upadhyay, K
    Thomson, A
    Luckas, MJM
    FETAL DIAGNOSIS AND THERAPY, 2005, 20 (06) : 512 - 514
  • [45] CONGENITAL MYOTONIC-DYSTROPHY - REPLY
    HARPER, PS
    ARCHIVES OF DISEASE IN CHILDHOOD, 1976, 51 (02) : 160 - 160
  • [46] AN INFANT WITH CONGENITAL MYOTONIC DYSTROPHY PHENOTYPE
    Jeffries, K.
    Philips, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 361 - 362
  • [47] Myotonic dystrophy protein kinase of the cardiac muscle: Evaluation using an immunochemical approach
    Schiavon, G
    Furlan, S
    Marin, O
    Salvatori, S
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 58 (05) : 404 - 411
  • [48] Localization of myotonic dystrophy protein kinase in skeletal muscle and its alteration with disease
    Dunne, PW
    Ma, L
    Casey, DL
    Harati, Y
    Epstein, HF
    CELL MOTILITY AND THE CYTOSKELETON, 1996, 33 (01): : 52 - 63
  • [49] Developmental regulation of myotonic dystrophy protein kinase in human muscle cells in vitro
    Kameda, N
    Ueda, H
    Ohno, S
    Shimokawa, M
    Usuki, F
    Ishiura, S
    Kobayashi, T
    NEUROSCIENCE, 1998, 85 (01) : 311 - 322
  • [50] CONGENITAL MYOTONIC-DYSTROPHY AND MTDNA
    POULTON, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 1992, 50 (03) : 651 - 651